3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
1
Neoplasms
1
Epilepsy
1
Interventions
Levetiracetam
6
perampanel
2
Tranexamic Acid
2
ziprasidone
1
Zolpidem
1
Warfarin
1
Vigabatrin
1
Vecuronium Bromide
1
Vancomycin
1
Tobramycin
1
Standard of Care
1
Spironolactone
1
Sodium Chloride
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Remifentanil
1
Propofol
1
Pregabalin
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Magnesium Sulfate
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Seizures
×
Vigabatrin
×
Clear all
NCT01266291
2017-07-12
STARS
University of Pennsylvania
Phase 4
Terminated
1 enrolled
8 charts